Skip to content

Clinical trials

Food Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Food Hypersensitivity Country / region: United States Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20065
20075
20085
20094
201010
20115
20126
201313
20144
20158
20163
201710
20186
20195
20206
202110
20224
20235
20244
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78
Terminated20
Recruiting15
Active, not recruiting8
Unknown status7
Not yet recruiting3
Withdrawn3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)16
Johns Hopkins University10
University of North Carolina, Chapel Hill8
DBV Technologies7
Stanford University6
National Jewish Health5
Novartis Pharmaceuticals5
Icahn School of Medicine at Mount Sinai4
Baylor College of Medicine3
Hugh A Sampson, MD3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Food Hypersensitivity136
Peanut Hypersensitivity47
Hypersensitivity27
Milk Hypersensitivity18
Dermatitis, Atopic14
Hypersensitivity, Immediate12
Eosinophilic Esophagitis10
Egg Hypersensitivity9
Asthma8
Anaphylaxis7

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.